(Reuters) - Drug maker Dendreon Corp is looking for a suitor after sales for its lead product, prostate cancer drug Provenge, were weaker than expected, according to a Bloomberg report. The Seattle-based company is working with JPMorgan Chase & Co...
Source: http://health.yahoo.net/news/s/nm/drug-maker-dendreon-seeking-a-buyer-report
resource source here i found it found it for you
No comments:
Post a Comment
Note: only a member of this blog may post a comment.